Old Web
English
Sign In
Acemap
>
authorDetail
>
Yuzuka Kanno
Yuzuka Kanno
Tokyo University of Science
Chemistry
Cancer research
MHC class I
Immunotherapy
Immune checkpoint
4
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells.
2021
Cancer immunology research
Chang-Yu Chen
Satoshi Ueha
Yoshiro Nagakute Aza-arata Ishiwata
Shigeyuki Shichino
Shoji Yokochi
De Yang
Joost J. Oppenheim
Haru Ogiwara
Shungo Deshimaru
Yuzuka Kanno
Hiroyasu Aoki
Tatsuro Ogawa
Shiro Shibayama
Kouji Matsushima
Show All
Source
Cite
Save
Citations (1)
Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers
2021
Frontiers in Oncology
Yuzuka Kanno
Chang-Yu Chen
Hsin-Lun Lee
Jeng Fong Chiou
Yin-Ju Chen
Show All
Source
Cite
Save
Citations (2)
A Combined Systemic Strategy for Overcoming Cisplatin Resistance in Head and Neck Cancer: From Target Identification to Drug Discovery.
2020
Cancers
Yin-Ju Chen
Guo-Rung You
Meng-Yu Lai
Long-sheng Lu
Chang-Yu Chen
Lai-Lei Ting
Hsin-Lun Lee
Yuzuka Kanno
Jeng Fong Chiou
Ann-Joy Cheng
Show All
Source
Cite
Save
Citations (2)
Combining an alarmin HMGN1 peptide with PD-L1 blockade facilitates stem-like CD8+ T cell expansion and results in robust antitumor effects
2020
bioRxiv
Chang-Yu Chen
Satoshi Ueha
Yoshiro Nagakute Aza-arata Ishiwata
Shigeyuki Shichino
Shoji Yokochi
De Yang
Joost J. Oppenheim
Haru Ogiwara
Shungo Deshimaru
Yuzuka Kanno
Tatsuro Ogawa
Shiro Shibayama
Kouji Matsushima
Show All
Source
Cite
Save
Citations (2)
1